CETP levels rather than polymorphisms as markers of coronary risk: healthy athlete with high HDL-C and coronary disease--effectiveness of probucol.
Cesare R
CR
Sirtori
Laura
L
Calabresi
Damiano
D
Baldassarre
Guido
G
Franceschini
Angelo B
AB
Cefalù
Maurizio
M
Averna
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002352:Carrier Proteins / Q000097:blood / Q000235:genetics*; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood* / Q000188:drug therapy / Q000235:genetics; D004247:DNA / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006023:Glycoproteins / Q000097:blood / Q000235:genetics*; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic; D011341:Probucol / Q000627:therapeutic use*; D013177:Sports
D000924:Anticholesteremic Agents; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D006023:Glycoproteins; D004247:DNA; D011341:Probucol